Non-Opioid EXPAREL Shows Health, Economic Benefits
Pooled data show that EXPAREL® (bupivacaine liposome injectable suspension) slashes opioid consumption, risk of opioid- related side effects, length of postsurgery hospital stay, and cost.
Pooled data show that EXPAREL® (bupivacaine liposome injectable suspension) slashes opioid consumption, risk of opioid- related side effects, length of postsurgery hospital stay, and cost.
Post-hoc analyses of phase III trials suggest some patients experienced improvements within days of treatment for atopic dermatitis and prurigo nodularis.